{"name":"OliPass Corporation","slug":"olipass-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxPNVRSMUtERVNLT3BpVk9iVkJnS1ZNdFc5QmZIOXVtcTdFcFVtaWtqRnB5WVNpRGp1WE8yNkYwYUMyZFlnaXAyaG5abXlPZS0tZXdIWlZvTmZ0ci1od0VHZkM1cE41bXRmaWFjVzFwcTVZbFdISWMwZ0gxc0hYZW9KZnJBLV9aYXQzdXV3S2E2c0pmOElDRnNzRlJiOHlxMURoYUdjR0tnNUFzNUdZSTNOUGpDRFJwU0lFY2RHTnpuQWlfUDhiVm04RXVDVlFFUV9IczM2cEtlWDJWbVZTQlR2dDkzOURkZ29IWUZuUFJHbll2TXhuYU42ZFRpSVloVG9QVE0tSl93Z21sdVNRLXNTcURZdUNmUGc2czRIcTZETTUxbllPTTNjV1FuNG5MWWQzVTA3V3Q2SVFLZTE5TGRFeFpwQ0l1eTlQbUxsbl9uYw?oc=5","date":"2026-03-25","type":"trial","source":"Barchart.com","summary":"Osteoarthritis Clinical Trial Pipeline Advances as 100+ Companies Develop 110+ Novel Therapies Across All Clinical Stages, Finds DelveInsight | Biosplice Therapeutics, Regeneron Pharmaceuticals - Barc","headline":"Osteoarthritis Clinical Trial Pipeline Advances as 100+ Companies Develop 110+ Novel Therapies Across All Clinical Stage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxNUDVMZkhtQjNwdVZkSTBlNmREMmNoOWxmaDYweDVuNlZsa0hzM0dkTVdYMG1zNHNMSHNmaWIwY3lZUU1WUnZBZEZacHkybnpsZlplV0JpckNnaFhIRXE2RHZ0MDFqVlRwLTdvYVlkZGdJMUhGczYxdlVfblR0a0gyWk16TXM0VnFmVlkyY3ZrTGZrc01GWmsxcFVfZ181Xzl6Mzg1d01fYXRUNnF4S2FRSjNwUDBEd0lpakUzbmI2RUdEd3BLbXhKMzVMRVRFM3Bqa05xWkQyZW9ybFNweEU1empPa0pFa0t4Yk1kS0xEYmFLSkZLelhYblRNMUl2akRsSFVxNmhjOURPRHp4X0ZoNlZLQWI2ei1rdTY5RnBIbVFqWC1qVlFxYUxZNm1OWDQwZEE?oc=5","date":"2025-08-28","type":"regulatory","source":"prnewswire.com","summary":"Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera - prnewswire.com","headline":"Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBGalQtZy1OU0J2TVFuSVFQVkpacDhjLWhHb3lHaFh2UENkUTE0SXRUQXZRQmI0RGhHQXdMb1puTm44OVppcDRsZ0x5c3ZOTHZPWGJ2YUthYWlyM2lFeFhQSXFPaEh1M3I1?oc=5","date":"2025-07-10","type":"regulatory","source":"MarketBeat","summary":"Vanda Pharmaceuticals (VNDA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat","headline":"Vanda Pharmaceuticals (VNDA) FDA Approvals, PDUFA Dates & Drug Alerts 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNVEJwUGRkeHZzLVdhaV9RRmdGbThzM0hHc0RTOTR0dzdtZUZYb1hQckhxMDNGRDVMem1rOVBkRm5ldERIN0xSY18xMXc1MGtOWW9QQVZrWDBBZ24xblFjRjhlaTg5MTVPU3hEUmNBNUJUZUFLTloyTGdvTkFpX1FiM0l2ajQ4U05zamtUZWpZSHhjaXRUeDFTVExtMUVTV1FsVno3TmFCREdLb0JiOU1IV3gxLTRrNmlNYnZtWmxNcDkzT1ZvMG9xd01zYWNNTGpGeUJEb2txcU9XR3JNNFZweGRyUUUwYTFIeFd3?oc=5","date":"2024-11-14","type":"pipeline","source":"GlobeNewswire","summary":"Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight - GlobeNewswire","headline":"Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQNk10S2RsVS1CRG1WeVBjVTN3N0pIbUE5TnRrdjh0TWJkZmluZ1FlS2tDdnl5clNYV1VMcXFFYjhKTlRNUVJadEJWeFRsd01hUnRXeVlLLXpmYWtwMWg2Y2lkX0g5b09RX3JEcjB5a1k1TXlUbHNqZ0t3bFl6TGE1Vy1fVXZYcWlsQmJkMmVDR3F3NWVTYjFqbnUwdGREQkF4TUk3aFBRMVQ3Q3ZaQ1MxWXYtRk9feGpHVlFwUEJRbF9URDlaTmVOOTlnU2k2N3VUQzg2MlJteGtlMHZxMlY0QmVFbXhFdVZlUmdRYi1TbFZNcDAtREVz?oc=5","date":"2024-10-24","type":"pipeline","source":"GlobeNewswire","summary":"Global Anti-Aging Products Market is Projected to Cross ~USD 112 Billion by 2030 | DelveInsight - GlobeNewswire","headline":"Global Anti-Aging Products Market is Projected to Cross ~USD 112 Billion by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxPejRGZWJpTmZNNWVJdm9YTHBrVk5xakRVV1NsbVhjQUxiVm9rbTc5OXBkMUpfVmRGMW9MOFpCcUliakR0emU4UjBrWUNIZWZQRlhoVEU1ODhHUWcxOGdkY3hIektmaGRoVDJMX1hTSllXTnBjbi1qYlE3cHY5QTN1SW1VcHpnc1NJbDdpcElkZW5JbmNiZ24taE5sVWRWZ0VIVkNYOHdvSTZXYVpKOXZDSFpNLVFlOEZJaFFxQkFLckM4WlA1aTJwT01XcW4xREsya0JYT1JJcHRHYmJwMExJNzRmeEYzZU1kTVNNdm5kVUlzN2xvcEJpWG8wNnBoU000N2Z4N2FvSU5pY29zeVFHNkVMbUU3RzhSbFh0a0hQNVE0eVFOQk4wdjBZYlg?oc=5","date":"2024-08-15","type":"pipeline","source":"GlobeNewswire","summary":"Global Non-Steroidal Anti-Inflammatory Drugs Market is - GlobeNewswire","headline":"Global Non-Steroidal Anti-Inflammatory Drugs Market is","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1pV2xZUXg3Z1RESDFSS1V2ek9DU2JSX1gyVHRGYVBLbzB3eTRWVmZWMExPSzdWYUNXZTdCczl6ekJ4cGF0dks5VEZMeU5tYlpqV2xuYUJEUW93ZVoyRU5ETG1JS0RCZ0ZPSTRrYTFn0gFyQVVfeXFMTTE0MjFyd1NteGVqT1FpWG5wb2FwWmR0aTB6b2p2Z3ctNUZyVXpTV2ZPc3BfUl9Yb3otMjR2aG9XWHNrZGxkdzNRMkVLb3YtbzN3ZkNEQXV2ZnRKUkNWdEtELVBvb2o2RHdhcmNMejhTeWNB?oc=5","date":"2022-10-28","type":"pipeline","source":"koreabiomed.com","summary":"OliPass receives $3 million upfront from Vanda Pharmaceutical for RNA-based treatment - koreabiomed.com","headline":"OliPass receives $3 million upfront from Vanda Pharmaceutical for RNA-based treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxPQmFFbnpraWREUkRtdEVNOVg1QjFFSnE0OWhGeFRCcDgtZlNRRjBRb29KMHMtT2VtTzE4SUhhSE5KcnpzeXhSaWNJeFFHbTBoQXJkSVpXQjROOXZtZlRyN2htMGh6QXN4cE41RG1lelV6NF94d2hyUEFiaTYxNDZpSVVad0gzb2V6Unl0ajJETnlHVWtZVlMzVkRvOTBVV2Z3N0RZZlpycktOOVY3c2d0RHEyYWlGay1ZUlNvRWlKVWZ6VW9JdGk1OHV5X0twVDROeE1GNVk3YXkxem00b09pY3RsZjk1T1dEam05Y1pHOTVaMUNPdjduamxGOWFTcTg?oc=5","date":"2022-09-29","type":"deal","source":"prnewswire.com","summary":"Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics - prnewswire.com","headline":"Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE1Tem5LeGN2V2NXeEZ3blBjZHFJRURLTVlNem1Qc3M1NkpDTWZEYjUxb19iUkhPQTlzMEFhcG5qNzlFQjRpZWk1Z0l0RmhCRHBTb2M4elpMZFc?oc=5","date":"2019-08-12","type":"pipeline","source":"theinvestor.co.kr","summary":"OliPass to inject W1.2b for establishing unit in US - theinvestor.co.kr","headline":"OliPass to inject W1.2b for establishing unit in US","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}